Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738774 · ClinicalTrials.gov registry record
Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)
A clinical trial of Post-Intensive Care Syndrome, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 200
- Enrollment target
- 5
- Study locations
NCT03738774: Active study of Post-Intensive Care Syndrome, sponsored by Vanderbilt University Medical Center.
NCT03738774 is a study of Post-Intensive Care Syndrome that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 200 participants, above the 155-participant average among 5 other Post-Intensive Care Syndrome trials with a reported enrollment target (29% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738774, a study of Post-Intensive Care Syndrome, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study will assess the relationship between early unmet needs after hospital discharge and subsequent clinical outcomes among survivors of acute respiratory failure. The investigators hypothesize that early unmet needs are associated with poor outcomes at three months.
Primary Outcome
Number of patients who died or were readmitted to the hospital within three month of hospital discharge
Conditions Studied
Study Locations (5)
Utah
- Intermountain Medical Center - Murray
- George Wahlen Salt Lake City Veterans Administration Hospital - Salt Lake City
Maryland
- Johns Hopkins Hospital - Baltimore
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2026-07 |
What the registry record for NCT03738774 still lists
NCT03738774 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 155-participant average among 5 other Post-Intensive Care Syndrome trials with a reported enrollment target (29% higher).
The record links to 1 condition, with Post-Intensive Care Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03738774 lists 5 locations in 4 states (Utah, Maryland, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03738774 about?
NCT03738774 is a clinical study titled "Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)". This study will assess the relationship between early unmet needs after hospital discharge and subsequent clinical outcomes among survivors of acute respiratory failure. The investigators hypothesize that early unmet needs are associated with poor outcomes at three months.
What is the current status of trial NCT03738774?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2019-01-02. Estimated completion is 2026-07.
What conditions does trial NCT03738774 study?
This clinical trial studies the following conditions: Post-Intensive Care Syndrome.
Who is sponsoring clinical trial NCT03738774?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03738774 being conducted?
This trial has 5 study locations across Maryland, Massachusetts, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Intensive Care Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Outcomes in PICS With Home-Based Program of Rehabilitation and Health Coaching
RECRUITING · NA
-
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
RECRUITING · NA
-
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
ACTIVE NOT RECRUITING · Phase 3
-
Multi-sensory Intervention Room Application (MIRA) Device in the NSICU
ACTIVE NOT RECRUITING · NA
-
Companion Dog Walking for ICU Survivor Health
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI